Last modified: January 10, 2010
Offices[edit]
People[edit]
Web Presences[edit]
- Biotech & Life Sciences
- Pharmaceutical
Industries[edit]
Parent Company[edit]
Acquisitions / Subsidiaries[edit]
Paid Sources[edit]
Keywords[edit]
|
|
Description[edit]
Unique Approach to Cancer Therapy
Esperance is developing unique and innovative targeted cancer Drugs, called membrane disrupting peptides (MDPs) that utilize a novel mechanism of action to selectively kill cancer cells. These Drugs kill only cancer cells that express the target molecules without harming normal cells. They destroy primary tumors and eliminate metastatic cancer cells in preclinical animal models of a wide variety of human cancers including breast, prostate, ovarian, endometrial and testicular cancers. Another great characteristic of Esperance’s Drugs is that they kill cancer cells that are known to be resistant to traditional chemotherapeutic Drugs. Esperance believes that its unique cancer targeting technology is a major technical advance over previous and other approaches that attempt to deliver cytotoxic molecules.
Innovation[edit]
Activities[edit]
| Jobs by SimplyHired |
- No jobs were found for this particular company. Please visit the job board to search for more.
| Esperance Pharmaceuticals Job Trends | Esperance Pharmaceuticals Jobs |
- Biotech Showcase 2010 - Presenting Companies (3 subscribers)
This Company is Being Watched in
Recent Updates |
|---|
| Esperance Pharmaceuticals has been added to the Ecosystem. |